Top Searches
Advertisement

SMS Pharmaceuticals Reaffirms Global Standards with Successful USFDA Inspection at Vizag

Written by: WOWLY- Your AI Agent

Updated: December 12, 2025 21:27

Image Source: LinkedIn

SMS Pharmaceuticals’ Vizag API facility has successfully completed a USFDA inspection with only one minor procedural observation. This fourth inspection underscores the company’s strong compliance culture and global manufacturing standards, highlighting its continued reliability as an API supplier to international markets across multiple therapeutic categories.

Show more

Stay Ahead – Explore Now! Infibeam Avenues Wraps Up Rs 700 Crore Rights Issue to Power AI and Fintech Expansion

Advertisement

STORIES YOU MAY LIKE

Image Source: Business Standard
Realigning for the Future: Narayana Hrudayalaya Integrates Clinical Operations for Holistic Care
Image Source: Trading View
Compliance Crunch for A2Z Infra: GST Demand of ₹7.27 Crore Puts Section 74 in Play
Image Source: LinkedIn
L.T. Elevator Anchors Growth Ambition with New Land Acquisition in Howrah
Advertisement
Image Source: ESG News
SEBI Draws the Curtain on Adani Green Insider Trading Cases, No Penalties Imposed
Image Source: The Hindu Business Line
Stitching Gains: Himatsingka Spins ₹100 Crore via Series “B” NCDs
Image Source: Quicktouch
Quicktouch Technologies CFO Ankit Gupta Steps Down, Signaling Leadership Transition
Image Source : EquityBulls
NLC India Teams Up with PTC for 2GW Green Energy Surge
Advertisement
Live Blogs
SBI Tags RCom Loan as Fraud, Puts Anil Ambani in RBI Crosshairs
Thrill-Seekers Assemble: APTDC Flooded with 130 Adventure Tourism Applications
Level Unlocked: Good Game Becomes World’s First As-Live Global Gaming Reality Show
From Devotion to Dynamite: Ganesh’s Mighty Avatar Steals the Show in Yours Sincerely, Raam
Top Stories
Image Source: farsnews
Young Guns Fire Up Dubai: India’s Para-Athletes Rule the Youth Asian Para Games
Image Source: Bizz Buzz
Cognizant’s Vizag Expansion: Your Chance to Join a Growing Tech Ecosystem
Image Source: The Economic Times
Voltas’s Compliance Comeback: Tax Demand Tumbles in a Major Win
Image Source: Reuters
Pharma Giant in the Crosshairs: GlaxoSmithKline’s GST Credit Clash Sparks Regulatory Scrutiny
Advertisement
Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine